TY  - JOUR
AU  - Calleja, Jose Luis
AU  - Rincón Rodríguez, Diego
AU  - Fernández Vázquez, María Inmaculada
AU  - Mariño, Zoe
PY  - 2017
DO  - 10.1016/j.jhep.2017.01.028
SN  - 0168-8278
UR  - https://hdl.handle.net/20.500.14352/114141
T2  - Journal of Hepatology
AB  - Background & AimsClinical trials evaluating second-generation direct-acting antiviral agents (DAAs) have shown excellent rates of sustained virologic response (SVR) and good safety profiles in patients with chronic hepatitis C virus (HCV) genotype 1...
LA  - eng
M2  - 1138
PB  - Elsevier
KW  - Hepatitis C Chronic
KW  - Genotype 1
KW  - Ombitasvir
KW  - Paritaprevir
KW  - Ritonavir
KW  - Dasabuvir
KW  - Ledipasvir
KW  - Sofosbuvir
KW  - Real-world
KW  - Antiviral agents
KW  - Sustained virologic response
KW  - Randomized controlled trials
TI  - Effectiveness, safety and clinical outcomes of direct-acting antiviral therapy in HCV genotype 1 infection: Results from a Spanish real-world cohort
TY  - journal article
VL  - 66
ER  -